Abstract:Tobacco smoke contains several electrophilic constituents which are capable of forming adducts with nucleophilic sites in DNA and proteins like hemoglobin (Hb) and albumin. New nicotine and tobacco products are discussed as less harmful forms of tobacco use compared to smoking combustible cigarettes (CC) due to reduced exposure to harmful constituents. Hence, the adduct profile in users of various tobacco/nicotine products is expected to differ characteristically. In this article, we present a novel nontargeted screening strategy using GC-MS/MS for Hb adducts based on the analysis of the respective derivatized N-terminal valine adducts after modified Edman degradation. We analyzed blood samples from a clinical study with habitual users of CCs, electronic cigarettes, heated tobacco products (HTPs), oral tobacco, nicotine replacement therapy products and nonusers of any tobacco/nicotine products. Our nontargeted approach revealed significant differences in the Hb adduct profiles of the investigated tobacco/nicotine product user groups. Adduct identification was performed by means of an internal database, retention time estimations based on the theoretical boiling points, as well as in-house synthesized reference compounds. Several chemicals that form adducts with Hb could be identified: methylating and ethylating agents, ethylene oxide, acrylonitrile, acrylamide, glycidamide and 4-hydroxybenzaldehyde. Levels were elevated in smokers compared to all other groups for Hb adducts from methylating agents, ethylene oxide, acrylonitrile, acrylamide and glycidamide. Our approach revealed higher concentrations of Hb adducts formed by ethylation, acrylamide and glycidamide in users of HTPs compared to nonusers. However, concentrations for the latter two were still lower than in smokers. Due to their long half-lives, Hb adducts related to acrylonitrile, acrylamide (glycidamide), and ethylene oxide exposure may be useful for the biochemical verification of subjects̀ compliance in longitudinal and cross-sectional studies with respect to smoking and HTP use/abstinence.

Histone Adduction with Nicotine: A Bio-Ams Study

Accelerator Mass Spectrometry Studies on Adduction of Nicotine with Hemoglobin and Serum Albumin in Mouse

Genotoxicity Study on Nicotine and Nicotine-Derived Nitrosamine by Accelerator Mass Spectrometry

The Conformation Alteration of Mouse Hepatic Histones after Reacting with Nicotine in Vitro

Accelerator Mass Spectrometry (ams) of the Inhibitory Effect of Six Dietary Constituents on Nicotine-Hemoglobin Adduction in Mice

Study of hemoglobin adduction with NNK in vivo by C-14-AMS

Decay Kinetics of Nicotine/Nnk-Dna Adducts in Vivo Studied by Accelerator Mass Spectrometry

Study of hemoglobin adduction with NNK in vivo by 14C - AMS

Analysis of methyl DNA adducts and metabolites in BEAS-2B cells induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone

Benzoate derived DNA adduction and its decay in mice measured by AMS

Identification of Specific Hemoglobin Adduct Patterns in Users of Different Tobacco/nicotine Products by Nontargeted GC-MS/MS Analysis

Incorporation And/or Adduction of Formic Acid with DNA in Vivo Studied by HPLC–AMS

Adduction of Biomacromolecules with Acrylamide (aa) in Mice at Environmental Dose Levels Studied by Accelerator Mass Spectrometry

Binding of Nitrobenzene to Hepatic DNA and Hemoglobin at Low Doses in Mice

Applications of 14C-AMS for Carcinogen, Pharmaceutical and Nutrient Studies

Exposure profiling of reactive compounds in complex mixtures

High Binding of Formic Acid to Biomacromolecules in Mice

The Assay of DNA Adducts in Cell System by AMS and Its Application

4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone-Induced Histone Acetylation via α7nAChR-Mediated PI3K/Akt Activation and Its Impact on γ-H2AX Generation

Mass spectrometry-based metabolomics study of nicotine exposure in THP-1 monocytes

In Vitro Interaction of Nicotine and Hemoglobin under Liver Cell Metabolizing Condition